Filing Details

Accession Number:
0000919574-14-001983
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-26 18:02:38
Reporting Period:
2014-02-24
Filing Date:
2014-02-26
Accepted Time:
2014-02-26 18:02:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278386 Broadwood Partners Lp C/O Broadwood Capital Inc.
724 Fifth Avenue, 9Th Floor
New York NY 10019
Yes No No No
1278387 Broadwood Capital Inc 724 Fifth Avenue
9Th Floor
New York NY 10019
Yes No No No
1278388 C Neal Bradsher C/O Broadwood Capital Inc.
724 Fifth Avenue, 9Th Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-24 71,000 $79.50 2,264,260 No 4 S Direct
Common Stock Disposition 2014-02-24 0 $0.00 2,264,260 No 4 S Indirect Footnote
Common Stock Disposition 2014-02-25 12,600 $80.08 2,251,660 No 4 S Direct
Common Stock Disposition 2014-02-25 0 $0.00 2,251,660 No 4 S Indirect Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect Footnote
No 4 S Direct
No 4 S Indirect Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,183 Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Broadwood Partners, L.P. on November 13, 2013. Broadwood Partners, L.P. is a reporting person.
  2. This constitutes the weighted average sale price. The prices range from $79.00 to $80.105. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  3. This constitutes the weighted average sale price. The prices range from $80.00 to $80.25. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  4. These securities are owned by Broadwood Partners, L.P.
  5. The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Broadwood Capital, Inc. and Neal C. Bradsher are each a reporting person. Each of Broadwood Capital, Inc. and Neal C. Bradsher disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  6. These securities are owned by Neal C. Bradsher.